COMMUNIQUÉS West-GlobeNewswire
-
Aprea Therapeutics Announces Closing of Oversubscribed $30 Million Private Placement
01/04/2026 -
VivoSim Announces Pricing of up to a $4 Million Public Offering
01/04/2026 -
Actinogen commences open-label phase of XanaMIA Alzheimer’s trial and provides business update
01/04/2026 -
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
01/04/2026 -
Alignment Healthcare to Present at the BofA Securities Health Care Conference 2026
01/04/2026 -
Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity
01/04/2026 -
FeraMAX est le supplemént de fer le plus recommandé au Canada depuis 11 années consécutives
01/04/2026 -
Stryker to announce financial results for its first quarter of fiscal year 2026
01/04/2026 -
Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference
01/04/2026 -
Soleo Health Selected as an Authorized Specialty Pharmacy of QIVIGY® For Primary Humoral Immunodeficiency (PI) Treatment
01/04/2026 -
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
01/04/2026 -
JenaValve Announces the Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the United States - the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR)
01/04/2026 -
RemoniHealth Expands Hardware-Free "Vision-as-a-Service" Platform to Cover Over 90% of Chronic Eye Diseases
01/04/2026 -
Grant of share-based long-term incentive instruments to members of the Board of Management and key employees
01/04/2026 -
NTG Nordic Transport Group (“NTG”) announces the appointment of Carsten Trolle as CEO of its Air & Ocean division
01/04/2026 -
Major Shareholder Announcement
01/04/2026 -
ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions
01/04/2026 -
AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
01/04/2026 -
Your Next Dental Appointment May Save Your Life
01/04/2026
Pages